| 21 |
|
Is The UK Still Open For Medtech Innovation Reimbursement?
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 22 |
|
J&J's approach to sourcing innovation: closing the networking gap
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2014
|
|
|
|
| 23 |
|
Marketing Efforts Pay Off As Admedus Ups CardioCel Centers By 50%
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 24 |
|
Masimo IP Verdict A Timely Warning For All Device Inventors, Says Counsel
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 25 |
|
Medtech innovation isn't dead, it's just different
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 26 |
|
Medtechs Should Not Play Dodgeball With Sales Force Effectiveness Adoption of sales force effectiveness remains suboptimal across the US medtech industry, which means that companies are missing out on significant annual revenue uplift
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 27 |
|
Medtechs Told: Change Commercial Models Or Be Left Behind
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 28 |
|
No End In Sight For M&A As Medtechs Adapt To The ``New Normal''
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 29 |
|
Olympus Targets A Bigger Medical Future
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 30 |
|
Pharmas Urged To Take Committed Steps Along The IDN Pathway
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 31 |
|
Single-Minded: Lombard Medical Aims For Double Top In Triple A
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2015
|
|
|
|
| 32 |
|
Uncertain Reg Climate Could Turn Medtech Investors Off Europe
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
| 33 |
|
Upwardly mobile: Toshiba breaks new ground in the medical imaging market
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2014
|
|
|
|
| 34 |
|
Value-Based Medtech Rides The Money-Go-Round Into 2016
|
Yeo, Ashley
|
Channing, Weinberg & Co
|
2016
|
|
|
|
